mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.007 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.028 |
0.5 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.3 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.02 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
0.058 |
0.09 |